• 1
    McGowan JE, Tenover FC. Control of antimicrobial resistance in the health care system. Infect Dis Clin North Am 1997; 11: 297311.
  • 2
    Shales DM, Gerding DN, John JF et al. Society for Healthcare Epidemiology of America and the Infectious Disease Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol 1997; 18: 275291.
  • 3
    Tice AD. Editorial response: impact of infectious diseases specialists. Clin Infect Dis 1999; 29: 6768.
  • 4
    Byl B, Clevenbergh P, Jacobs F et al. Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin Infect Dis 1999; 29: 6066.
  • 5
    Classen DC, Burke JP, Wenzel RP. Infectious diseases consultations: impact on outcomes for hospitalized patients and results of a preliminary study. Clin Infect Dis 1997; 24: 468470.
  • 6
    Cunney RJ, McNamara EB, Alansari N, Loo B, Smyth EG. The impact of blood culture reporting and clinical liaison on the empiric treatment of bacteremia. J Clin Pathol 1997; 50: 10101012.
  • 7
    Fluckiger U, Zimmerli W, Sax H, Frei R, Widmer AF. Clinical impact of an infectious disease service on the management of bloodstream infection. Eur J Clin Microbiol Infect Dis 2000; 19: 493500.DOI: 10.1007/s100960000306
  • 8
    Gomez J, Conde Cavero SJ, Hernandez Cardona JL et al. The influence of the opinion of an infectious disease consultant on the appropriateness of antibiotic treatment in a general hospital. J Antimicrob Chemother 1999; 38: 309314.
  • 9
    Wilkins EG, Hickey MM, Khoo S et al. Northwick Park Infection Consultation Service. Part II. Contribution of the service to patient management: an analysis of results between September 1987 and July 1990. J Infect 1991; 23: 5763.
  • 10
    Fowler VG, Sanders LL, Sexton DJ et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendation of infectious disease specialists: experience with 244 patients. Clin Infect Dis 1998; 27: 478486.
  • 11
    Nathwani D, Davey P, France AJ, Phillips G, Orange G, Parratt D. Impact of an infection consultation service for bacteraemia on clinical management and use of resources. Q J Med 1996; 89: 789797.
  • 12
    Coleman RW, Rodondi LC, Kaubisch S, Granzella NB, O'Hanley PD. Cost effectiveness of prospective and continuous parenteral antibiotic control: experience at the Palo Alto Veterans Affair Medical Center from 1987 to 1989. Am J Med 1987; 90: 439444.
  • 13
    Molstad S, Cars O. Major changes in the use of antibiotics following a national programme. Swedish Strategic Programme for the Rational Use of Antimicrobial Agents and Surveillance of Resistance (STRAMA). Scand J Infect Dis 1999; 31: 191195.
  • 14
    Gould IM, Jappy B. Trends in hospital antimicrobial prescribing after 9 years of stewardship. J Antimicrob Chemother 2000; 45: 913917.DOI: 10.1093/jac/45.6.913-a
  • 15
    Briceland LL, Nightingale CH, Quintiliani R, Cooper BW, Smith KS. Antibiotic streamlining from combination therapy to monotherapy utilizing an interdisciplinary approach. Arch Intern Med 1998; 148: 20192022.
  • 16
    Quintiliani R, Cooper BW, Briceland LL, Nightingale CH. Economic impact of streamlining antibiotic administration. Am J Med 1987; 82: 391394.
  • 17
    Marr JJ, Moffet HL, Kunin CM. Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Disease Society of America. J Infect Dis 1987; 157: 869876.
  • 18
    Gould IM, Jappy B. Trends in hospital antibiotic prescribing after introduction of an antibiotic policy. J Antimicrob Chemother 1996; 38: 895904.
  • 19
    John JF, Fishman NO. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin Infect Dis 1997; 24: 471485.